Set to open in May, this service is the first entry of a foreign oncology provider into Indonesia, enhancing cancer care for the region.
Bali International Hospital is strategically situated within the Sanur Special Economic Zone (SEZ), where the Ministry of Health has granted special concessions.
This includes allowing foreign doctors and healthcare professionals to practice, and providing access to oncology drugs not yet approved in Indonesia.
This partnership brings together Icon’s in-depth expertise in oncology and IHC’s strength in healthcare and hospital management to provide comprehensive end-to-end cancer care within the SEZ of Bali, Indonesia.
Icon’s extensive experience and expertise in oncology includes a global network of more than 350 doctors, over 50 cancer centres and six compounding facilities.
IHC runs one of the largest hospital networks in Indonesia with 38 hospitals across the archipelago including three facilities equipped with end-to-end capabilities. By combining our strengths, we are bringing high-quality cancer care closer to home for patients in Indonesia, ensuring timely and greater access to new evidence-based cancer treatments that are not yet available in Indonesia.
Icon ASEAN CEO, Serena Wee said this collaboration demonstrates Icon’s mission to deliver the best care possible, closer to home.
“We are honoured to be part of this transformative partnership, helping to redefine cancer care in Indonesia,” said Serena.
“For the first time, our doctors will be able to practice within the Sanur SEZ in Bali—a historic achievement for healthcare in this region. This is a unique opportunity that enables us to continue delivering exceptional cancer care and improving local access to high-quality treatments for our patients in Indonesia.”
dr Dewi F. Fitriana, President Director of Bali International Hospital, said this marks a significant step forward in the region’s cancer care.
“Cancer is the second leading cause of death among non-communicable diseases in Indonesia, with cases rising each year. More than 65% of cancer diagnoses occur at an advanced stage upon a patient’s first visit to a healthcare facility, highlighting the urgent need for high-quality oncology care,” said dr. Dewi.
“We have invested in the latest cutting-edge cancer treatment technologies and partnerships like Icon to provide our patients with exceptional care.”
Through this collaboration, both Icon and Bali International Hospital reaffirm a shared commitment to provide the world-class cancer care through a multidisciplinary approach. Furthermore, this partnership will support the healthcare transformation plan outlined by the Ministry of Health, driving progress in healthcare especially cancer care for the people of Indonesia.
Australian Trade and Investment Commissioner, Jakarta, Lauren Adams supports this milestone partnership.
“It’s great to see an Australian healthcare company supporting efforts in Indonesia,” said Lauren.
“Icon has a strong track record of delivering exceptional care across ASEAN, Australia and New Zealand and it’s through these collective capabilities we can turn the dial on cancer here in Indonesia and help bridge the care gap.”
Through this collaboration, Icon also aims to equip and upskill the local care team with the necessary knowledge and resources to provide holistic care and support throughout a patient’s cancer treatment.
Icon Group CEO, Mark Middleton OAM emphasises Icon’s commitment to elevating care.
“This partnership reinforces our commitment to improving access to world-class care in the region,” said Mark.
“Our Singapore and Malaysian doctors are highly experienced and have been caring for patients across Southeast Asia for decades. This venture brings their experience in delivering quality cancer care closer to home for Indonesian locals, extending our ability to help more people access care when and where they need it.”
Cancer care services at Bali International Hospital
State-of-the-art technology and equipment will form the foundation of Bali International Hospital’s cancer care services. Equipped with cutting-edge technologies such as 3D mammography, a 3.0 Tesla MRI, a 256-slice CT scanner, and PET-CT for thorough cancer diagnostics, along with Varian TrueBeam and SagiNova Brachytherapy systems to enhance treatment capabilities, BIH will provide Indonesian patients with access to the latest medical advancements. Combined with Icon’s expertise, this ensures patients receive top-tier treatment, offering them peace of mind throughout their journey.
About Bali International Hospital
Bali International Hospital, a subsidiary of IHC, is set to become Indonesia’s leading medical tourism destination. Located in the newly established Sanur-based Healthcare SEZ, the hospital spans 67,465 square meters across four floors and is scheduled to open in the second quarter of 2025. It will feature 255 beds with 34 intensive care rooms, 8 operating rooms, 4 cathlabs, and 5 centers of excellence, and advanced imaging and treatment capabilities.
As an integrated medical center, Bali International Hospital will provide comprehensive services in Cardiology, Oncology, Neurology, Gastroenterology, Orthopedics and Health Screening. Developed in collaboration with globally recognized institutions such as Icon Cancer Centre and Innoquest, the hospital will be supported by highly trained specialists and state-of-the-art diagnostic technology.
At Icon, you’ll help change lives, every single day. In return for your passion, dedication and agility, we offer a workplace where you can.
Icon Sunsuria announces partnership with Penang’s Island Hospital to elevate access to advanced cancer care in Malaysia.
Learn more about our cancer centre network in Malaysia
Read the latest news and updates across Icon Group